Related Experiment Video
Updated: Aug 24, 2025
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
The New SNOMED CT International Medicinal Product Model
Olivier Bodenreider1, Julie James2
1U.S. National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA.
Objectives:
To present the new SNOMED CT international medicinal product model.
Methods:
We present the main elements of the model, with focus on types of entities and their interrelations, definitional attributes for clinical drugs, and categories of groupers.
Results:
We present the status of implementation as of July 2018 and illustrate differences between the original and new models through an example.
Conclusions:
Benefits of the new medicinal product model include comprehensive representation of clinical drugs, logical definitions with necessary and sufficient conditions for all medicinal product entities, better high-level organization through distinct categories of groupers, and compliance with international standards.
Related Concept Videos
01:17Drug Nomenclature
01:02Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:25Drug Regulation